Publications by authors named "Mihaela Levitchi-Benea"

Article Synopsis
  • - Ongoing assessment in postapproval studies for Alzheimer's disease aims to track disease progression and evaluate the effectiveness and safety of treatments in real-world scenarios.
  • - The study faces challenges due to differences in data collection methods across various centers and the diversity of patients compared to those in clinical trials.
  • - Key design elements for these studies include specifying aims and objectives, identifying study populations, and establishing consistent methods for measuring cognition, function, safety, and quality of life.
View Article and Find Full Text PDF

Background: Alzheimer's disease (AD) substantially increases health-related costs. This study investigates direct medical costs and characterizes the caregiver burden across AD stages.

Methods: This study analyzed data from the French Primary Health Insurance Fund claims database and reflected this public payer perspective.

View Article and Find Full Text PDF

Introduction: Published estimates of Alzheimer's disease (AD) progression do not capture the full disease continuum. This study provides transition probabilities of individuals with amyloid-β (Aβ+) pathology across the disease continuum.

Methods: Patient-level longitudinal data from the National Alzheimer's Coordinating Center were used to estimate progression rates.

View Article and Find Full Text PDF